Development and Validation of a Patient Reported Experience Measure for Experimental Cancer Medicine
NCT05386602 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 570
Last updated 2024-10-04
Summary
This is a four stage, non-interventional study to develop and pilot test a Patient Reported Experience Measure (PREM) in experimental cancer medicine trials.
Conditions
Sponsors & Collaborators
-
The Christie NHS Foundation Trust
lead OTHER
Principal Investigators
-
Sally Taylor, PhD · The Christie NHS Foundation Trust
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-07-16
- Primary Completion
- 2023-10-31
- Completion
- 2023-11-20
Countries
- United Kingdom
Study Locations
More Related Trials
-
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
NCT05334069 ·Status: RECRUITING
-
Utilization of the OncoCEE™ Platform to Evaluate Selected Biomarker Alterations in CTCs Isolated From Patients With MBC
NCT02436772 ·Status: COMPLETED
-
Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom
NCT00757614 ·Status: UNKNOWN
-
Remote Digital Physiologic Data Collection in Cancer: An MSK Registry Protocol
NCT05390827 ·Status: RECRUITING
-
Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics
NCT05819827 ·Status: TERMINATED
-
Medical Data Collection in the Formation of Precision Oncology Registry
NCT03874065 ·Status: TERMINATED
-
Economic Evaluation of Innovative Molecular Analyses in Onco-haematology
NCT03750994 ·Status: UNKNOWN
-
Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment
NCT05600933 ·Status: ENROLLING_BY_INVITATION
-
Study of Genes and the Environment in Patients With Endometrial Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom
NCT00758056 ·Status: UNKNOWN
-
Characterization & Comparison of Drugable Mutations in Primary and Metastatic Tumors, CTCs and cfDNA in MBCpatients
NCT02626039 ·Status: COMPLETED
-
Genomic Sequencing in Determining Treatment in Patients With Metastatic Cancer or Cancer That Cannot Be Removed by Surgery
NCT02566421 ·Status: TERMINATED ·Phase: NA
-
Virus-associated Tumour Microenvironment: Characterisation and Immunological Mechanisms of Resistance to Anti-tumour Treatments
NCT07028866 ·Status: NOT_YET_RECRUITING
-
The Dynamic Monitoring of Cerebrospinal Fluid ctDNA
NCT06315686 ·Status: RECRUITING ·Phase: PHASE2
-
Molecular Characterisation of Appendiceal Cancer
NCT05364788 ·Status: RECRUITING
-
A Pilot Study Utilizing Proteomic and Genomic Profiling for Patients With Metastatic Breast Cancer
NCT01919749 ·Status: COMPLETED ·Phase: NA
-
Studying Biomarkers in Tumor Tissue and Blood Samples From Patients With Small Cell Lung Cancer Registered on CALGB-140202
NCT01503619 ·Status: COMPLETED
-
Genomic and Proteomic Profiling Targets Influenced Treatment in Metastatic Breast Cancer
NCT02470819 ·Status: WITHDRAWN ·Phase: NA
-
Collection of Blood From Patients With Cancer
NCT00034216 ·Status: RECRUITING
-
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
NCT03662204 ·Status: COMPLETED
-
Study of Genes and the Environment in Patients With Prostate Cancer Residing in the East Anglia, Trent, or West Midlands Regions of the United Kingdom
NCT00758173 ·Status: UNKNOWN
-
Evaluation of Different Analysis Methods for Circulating Tumor Cells, Circulating Endothelial Cell, and Circulating Tumor DNA in Patient Followed for a Tumoral Pathology
NCT02220556 ·Status: COMPLETED ·Phase: NA
-
PREcision Medicine in Cancer in Odense, Denmark
NCT05385081 ·Status: UNKNOWN ·Phase: NA
-
Biology and Genetics of Smouldering Myeloma
NCT05047107 ·Status: UNKNOWN
-
Precision Medicine for Patients With Identified Actionable Mutations
NCT04111107 ·Status: TERMINATED ·Phase: PHASE2
-
Feasibility Study of Genomic Profiling Methods and Timing in Tumor Samples
NCT01703585 ·Status: COMPLETED